December 2016 December 2016 Urology Times.png
Persistent decline in renal function seen after first stone case“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
Is 1.5 the new magic number for PSA screening?A new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing.
USPSTF reform: Will lame-duck Congress act?Over the past several months leading up to the November presidential and congressional elections, organizations representing urology sought to persuade members of Congress to bring sense and reason to the U.S. Preventive Services Task Force (USPSTF), which nearly 5 years ago gave a “D” rating to PSA-based screening for prostate cancer.
Uro Pipeline: Data from mUC combination therapy suggests efficacy, safetyOther pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism.
Study: Patients taking aspirin can safely undergo PCNLPercutaneous nephrolithotomy in the presence of aspirin appears both effective and safe. In a retrospective review of almost 300 PCNL cases, postoperative hemorrhage was uncommon in patients who continued aspirin preoperatively, said Brandon Otto, MD, at the AUA annual meeting in San Diego.
CMS releases pay, Quality Payment Program rules
Final rule: Good news, bad news for urologistsIn this article, I outline what urologists should know about major provisions in the 2017 Medicare Physician Fee Schedule and how it may impact their bottom line.
Patient dies after prostatectomy; is his urologist at fault?
Estate planning: Don’t make these mistakesHere is a list of potential estate-planning mistakes you can help avoid with professional counseling.
Study: CT urogram leads to costly follow-up imagingFindings from an initial cost analysis support further research and reconsideration of the role of computed tomography urography for imaging evaluation in patients with asymptomatic microhematuria, according to urologists from the University of Alabama at Birmingham.
Few prostate Ca patients with BCR develop metastasisFewer than 20% of patients with biochemical recurrence after radical prostatectomy develop metastasis, and a smaller proportion die as a result of prostate cancer.
Mathematical model may predict PCa tumor growth, evolutionThe novel tool could result in earlier prostate cancer diagnoses and less invasive testing, although a prostate cancer expert cautioned that the model makes multiple assumptions and has not been validated.
Nomogram helps predict biochemical failure risk post RPUse of the nomogram, along with factors such as PSA level and family history, is a reliable, useful tool for helping urologists and their patients make better treatment decisions, says the author of a recent study.
Polycythemia risk evaluated in patients on TRT pelletsResearchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.
Aerobic exercise boosts testosterone levelsOverweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.
Role of LND in patients undergoing radical nephroureterectomy
Buried penis repair: Videos illustrate aesthetic, functional considerationsThese four videos depict expert techniques for buried penis repair.
High-grade bladder Ca: New data improve risk stratification“We need to identify those patients with high-grade T1 bladder cancer that are likely to recur or progress… and find additional options to prevent recurrence and progression in these patients,” said Joaquim Bellmunt, MD, PhD, in a presentation at the SUO annual meeting.
RCC: Multiple pathways provide therapeutic targetsRead highlights from a presentation by Toni K. Choueiri, MD, at the Society of Urologic Oncology annual meeting.
MACRA leaves urologists confused, skepticalThe era of value-based health care has arrived. And while the idea of basing reimbursement on quality and efficiency rather than volume of care is good in theory, the majority of urologists say it will be difficult to carry out, according to Urology Times' 2016 State of the Specialty survey.
Are you unhappy? Survey reveals why
Top apps for urologistsFrom AUA guidelines to a prostate cancer risk calculator, here are some useful apps recommended by urologists.
Top 10 prostate cancer articles of 2016These are Urology Times' most-read prostate cancer articles of 2016.
Study examines link between inflammation, prostate CaResearchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.
How will health care change under a Trump presidency?"I don’t know what to expect from any aspect of the President Trump camp. There is so much vagueness in what he says," one urologist said.
How Trump will change health care: UT’s board members weigh in“I am concerned about decreased federal support impacting urologic clinical practices and research progress,” Arthur L. Burnett, II, MD, MBA, told Urology Times.
Top 5 malpractice articles of 2016Discussion of cases involving alleged delay in testis cancer diagnosis, bowel perforation during robotic radical prostatectomy, and arterial injury during nephrectomy were among the most read “Malpractice Consult” articles from 2016.
MUSIC: How statewide initiative is improving care, outcomesIn this interview, Khurshid R. Ghani, MD, and David C. Miller, MD, MPH, discuss the origins of the Michigan Urological Surgery Improvement Collaborative, what it’s done for prostate cancer care in Michigan, and how a similar model could be rolled out nationally.
New study supports MET for larger ureteric stonesA recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Top 5 blog posts by Dr. Henry Rosevear
Lifestyle creep: What is it, and how do you avoid it?